Tech Company Financing Transactions

Ventaira Pharmaceuticals Funding Round

TL Ventures, Battelle Ventures and Fletcher Spaght Ventures participated in a $13.5 million Series C venture round for Ventaira Pharmaceuticals. The round was announced by the company on 3/30/2005.

Transaction Overview

Company Information

Company Status

Acquired or Merged

Industry

Biopharmaceutical

Mailing Address

1801 Watermark Drive 100
Columbus, OH 43215
USA

Phone

(643) 215-1037

Website

www.ventaira.com

Email Address

Not Recorded

Overview

Ventaira Pharmaceuticals is an emerging specialty pharmaceutical company focused on the development of new inhalation products by utilizing its novel proprietary ele ctrohydrodynamic (EHD) aerosolization and formulation technologies.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Leslie Williams

        

Chief Financial Officer

Janice Beauchamp

        

VP - Product Management

John Denny

        

VP - R & D

Lex Adjei

        

Browse more venture capital transactions:

Prev: 3/30/2005: Confluent Surgical venture capital transaction
Next: 3/31/2005: Siimpel venture capital transaction

Share this article

About Database of VC Transactions

Our team works diligently to report on tech company VC transactions. All VC database entries reported here are derived from publicly available VC deal announcements. The data is sourced from VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary